An online seminar which will be of interest to TB and HIV researchers, students, as well as researchers in childhood diseases.
Until recently, pregnant women have been excluded from clinical trials of DR-TB drugs. For 12 years, the South African Medical Research Council have been running a cohort of pregnant women with DR-TB documenting maternal treatment, pregnancy and infant outcomes after one year. During this time, treatment regimens have changed from two-year long regimens with an injectable to 6-month oral regimens. However, for individual patient and health systems reasons, the improvement in maternal treatment outcomes has been minimal and infants are at risk of TB.
Speaker
Marian Loveday, South African Medical Research Council
Marian joined the South African Medical Research Council after working for 15 years at different levels of the public health system in South Africa. Most of her research has been in health systems and operational research through the lens of TB, DR-TB and HIV. Using qualitative methodologies, she have explored sub-optimal ART adherence in adolescents and people hospitalised with advanced HIV disease.
Event notices
- Please note this event is virtual only.
- Please note that the recording link will be listed on this page when available.
Admission
Contact
